110 studies found for:    "retinitis pigmentosa"
Show Display Options
Rank Status Study
21 Enrolling by invitation Feasibility and Safety of Adult Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Other: Intravitreal injection of bone marrow-derived mesenchymal stem cells
22 Completed A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: NT-501
23 Recruiting Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
Conditions: Macular Oedema;   Retinitis Pigmentosa
Intervention: Drug: Aflibercept
24 Recruiting Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Usher Syndrome Type 2;   Usher Syndrome Type 3
Intervention: Drug: NT-501
25 Completed Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes
Condition: Autosomal Dominant Retinitis Pigmentosa
Intervention: Genetic: genetic analysis
26 Completed Randomized Trial for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Vitamin A;   Drug: Nutritional Supplement
27 Recruiting Biomarkers In Retinitis Pigmentosa (BIRP)
Condition: Retinitis Pigmentosa Patients
Intervention: Other: AC tap
28 Completed Effects of Lutein in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: Lutein (10 or 30 mg/day) capsules
29 Completed
Has Results
DHA and X-Linked Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   X-linked Genetic Diseases
Intervention: Drug: docosahexaenoic acid OR corn/soy oil placebo
30 Completed Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: transcorneal electrostimulation
31 Recruiting Safety and Tolerability of hRPC in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: hRPC
32 Completed Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Procedure: hyperbaric oxygen therapy
33 Recruiting Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Biological: Intravitreal injection of Autologous bone marrow Stem Cell;   Other: Subconjunctival injection of saline
34 Active, not recruiting Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
Conditions: Retinitis Pigmentosa;   Cystoid Macular Edema
Interventions: Drug: rhNGF 180 µg/ml eye drops solution;   Drug: vehicle eye drops
35 Terminated Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: UF-021;   Drug: Placebo
36 Not yet recruiting The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Dietary Supplement: Alga Dunaliella Bardawil powder;   Dietary Supplement: Placebo:Starch
37 Recruiting Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa (RP)
Intervention: Biological: human retinal progenitor cells
38 Completed Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Condition: Retinitis Pigmentosa (RP)
Intervention: Drug: QLT091001
39 Completed Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
40 Completed Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years